To Speak to a Research Nurse
617-726-7851

Most clinical trials in the program are NCI/NABTT-sponsored phase I and II studies, with our investigators currently serving as national chairs of three such studies. In addition, institution was designated as the Pharmacology Core Laboratory for NABTT in 2004. The Neuro-Oncology Program is also an active participant in studies of agents designed to enhance the sensitivity of tumor cells to ionizing radiation as part of the Radiation Therapy Oncology Group (RTOG). In addition to these approaches, the hospital is an international leader in the development of gene therapy for malignant gliomas. An NIH funded program project in the gene therapy of gliomas has led to a phase I trial of viral vector-based gene therapy for recurrent malignant gliomas.

Visit the new cancer research website regarding ongoing clinical research in cancers of the brain and central nervous system.